New hope for patients with rare, aggressive blood cancer
NCT ID NCT06043674
Summary
This study is testing whether a drug called Glofitamab works better alone or when combined with other cancer drugs to treat Richter's Transformation. This is a fast-growing lymphoma that can develop in people with chronic lymphocytic leukemia. About 70 adults with this condition will receive treatment for about 9 months and be followed for up to 10 years to see how well the treatments work and how safe they are.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC LYMPHOCYTIC LEUKEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Brigham and Women's Hospital
RECRUITINGBoston, Massachusetts, 02215, United States
Contact
Contact Email: •••••@•••••
-
Dana Farber Cancer Institute
RECRUITINGBoston, Massachusetts, 02215, United States
Contact
Contact Email: •••••@•••••
-
The Ohio State University Comprehensive Cancer Center
RECRUITINGColumbus, Ohio, 43210, United States
Contact Email: •••••@•••••
Contact
-
The University of North Carolina at Chapel Hill
RECRUITINGChapel Hill, North Carolina, 27599, United States
Contact Email: •••••@•••••
Contact
-
Winship Cancer Institute at Emory University
RECRUITINGAtlanta, Georgia, 30322, United States
Contact Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.